| 08/04/2021 |
General (Non-Research) |
Cash or cash equivalent |
Honoraria |
$500.00 |
Details |
| Payment from |
Philips Electronics North America Corporation |
| Payment Record ID |
853245985 |
|
| 12/09/2021 |
General (Non-Research) |
Cash or cash equivalent |
Honoraria |
$250.00 |
Details |
| Payment from |
Philips Electronics North America Corporation |
| Payment Record ID |
853245983 |
|
| 12/20/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$580.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
848717383 |
|
| 09/07/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$480.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
848717355 |
|
| 12/20/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$120.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
848644029 |
|
| 02/25/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$240.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
848609677 |
|
| 07/16/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1800.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
848573019 |
|
| 10/25/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$140.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
848462691 |
|
| 10/25/2021 |
Research |
Cash or cash equivalent |
|
$60.00 |
Details |
| Payment from |
BeiGene (Suzhou) Co., Ltd. |
| Paymment Research Study |
An Open Label, Multi-Center Phase I/II Study to Evaluate Efficacy and Safety of BGB-290 in Chinese Subjects With Advanced Ovarian Cancer, Fallopian Cancer, and Primary Peritoneal Cancer or Advanced Triple Negative Breast Cancer |
| Clinical Trials Gov ID |
NCT03333915 |
| Payment Record ID |
843875259 |
|
| 11/23/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$300.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191893 |
|
| 12/20/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$200.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191889 |
|
| 09/07/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$200.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191865 |
|
| 05/27/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$650.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191797 |
|
| 12/20/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$150.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191793 |
|
| 10/14/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$250.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191761 |
|
| 09/17/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$150.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191695 |
|
| 07/16/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$850.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
833191679 |
|
| 02/25/2021 |
Research |
Cash or cash equivalent |
|
$110.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, PLACEBO-CONTROLLED, INTERNATIONAL, MULTICENTRE STUDY TO ASSESS EFFICACY AND SAFETY OF CX601, ADULT ALLOGENEIC EXPANDED ADIPOSE-DERIVED STEM CELLS (EASC) FOR THE TREATMENT OF COMPLEX PERIANAL FISTULA(S) IN PATIENTS WITH CROHN'S DISEASE OVER A PERIOD OF 24 WEEKS AND A FOLLOW-UP PERIOD UP TO 52 WEEKS |
| Clinical Trials Gov ID |
NCT03279081 |
| Payment Record ID |
816643619 |
|
| 10/29/2021 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$14.27 |
Details |
| Payment from |
BOSTON SCIENTIFIC CORPORATION |
| Payment Record ID |
793757267 |
|
| 09/17/2021 |
Research |
Cash or cash equivalent |
|
$1590.00 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Paymment Research Study |
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma |
| Payment Record ID |
787571651 |
|
| 09/07/2021 |
Research |
Cash or cash equivalent |
|
$3540.00 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Paymment Research Study |
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma |
| Payment Record ID |
787571641 |
|
| 07/16/2021 |
Research |
Cash or cash equivalent |
|
$3285.00 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Paymment Research Study |
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma |
| Payment Record ID |
787571629 |
|
| 05/27/2021 |
Research |
Cash or cash equivalent |
|
$1275.00 |
Details |
| Payment from |
Janssen Research & Development, LLC |
| Paymment Research Study |
A Study of the Bruton's Tyrosine Kinase Inhibitor Ibrutinib Given in Combination With Bendamustine and Rituximab in Patients With Newly Diagnosed Mantle Cell Lymphoma |
| Payment Record ID |
787571619 |
|
| 12/17/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$400.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
747839203 |
|
| 12/28/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$300.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
747839201 |
|
| 11/25/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$360.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
747829897 |
|
| 10/15/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2000.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
747798245 |
|
| 09/21/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3640.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
747776711 |
|
| 09/01/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2020.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
747776709 |
|
| 06/18/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$400.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
747619895 |
|
| 12/17/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$500.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743633531 |
|
| 12/28/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$50.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743633527 |
|
| 11/25/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$200.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743497795 |
|
| 09/01/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$550.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743497793 |
|
| 09/21/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$150.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743497789 |
|
| 10/15/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$300.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743497785 |
|
| 05/26/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1400.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743280413 |
|
| 09/01/2020 |
Research |
Cash or cash equivalent |
|
$710.00 |
Details |
| Payment from |
AbbVie Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
721141915 |
|
| 04/20/2020 |
Research |
Cash or cash equivalent |
|
$270.00 |
Details |
| Payment from |
AbbVie Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
721141913 |
|
| 02/27/2020 |
Research |
Cash or cash equivalent |
|
$170.00 |
Details |
| Payment from |
AbbVie Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
721141911 |
|
| 01/16/2020 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
AbbVie Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
721141909 |
|
| 11/27/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$460.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
695871961 |
|
| 09/19/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2160.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
695816355 |
|
| 05/30/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$600.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
695771681 |
|
| 09/05/2019 |
Research |
Cash or cash equivalent |
|
$330.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158539 |
|
| 07/03/2019 |
Research |
Cash or cash equivalent |
|
$275.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158537 |
|
| 09/26/2019 |
Research |
Cash or cash equivalent |
|
$220.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158535 |
|
| 05/02/2019 |
Research |
Cash or cash equivalent |
|
$495.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158533 |
|
| 05/30/2019 |
Research |
Cash or cash equivalent |
|
$350.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158531 |
|
| 01/24/2019 |
Research |
Cash or cash equivalent |
|
$495.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158529 |
|
| 10/31/2019 |
Research |
Cash or cash equivalent |
|
$165.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158527 |
|
| 11/27/2019 |
Research |
Cash or cash equivalent |
|
$165.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158525 |
|
| 12/26/2019 |
Research |
Cash or cash equivalent |
|
$440.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158523 |
|
| 04/04/2019 |
Research |
Cash or cash equivalent |
|
$55.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158521 |
|
| 10/31/2019 |
Research |
Cash or cash equivalent |
|
$385.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158519 |
|
| 02/28/2019 |
Research |
Cash or cash equivalent |
|
$190.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Paymment Research Study |
Adult Allogeneic Expanded Adipose-derived Stem Cells eASC for the Treatment of Complex Perianal Fistulas in Patients With Crohn's Disease ADMIRE-CD-II |
| Payment Record ID |
686158517 |
|
| 08/05/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3704.00 |
Details |
| Payment from |
GUERBET LLC |
| Payment Record ID |
686066857 |
|
| 08/05/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$93.75 |
Details |
| Payment from |
GUERBET LLC |
| Payment Record ID |
686066853 |
|
| 09/05/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1650.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
673756207 |
|
| 12/26/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$850.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
673754467 |
|
| 08/01/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$100.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
673754465 |
|
| 11/27/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$50.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
673754463 |
|
| 02/28/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1700.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
672318121 |
|
| 05/02/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$400.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
672295535 |
|
| 12/26/2019 |
Research |
Cash or cash equivalent |
|
$360.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629709 |
|
| 11/27/2019 |
Research |
Cash or cash equivalent |
|
$3630.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629707 |
|
| 10/31/2019 |
Research |
Cash or cash equivalent |
|
$1520.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629705 |
|
| 09/26/2019 |
Research |
Cash or cash equivalent |
|
$220.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629703 |
|
| 09/05/2019 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629701 |
|
| 07/03/2019 |
Research |
Cash or cash equivalent |
|
$4120.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629699 |
|
| 07/03/2019 |
Research |
Cash or cash equivalent |
|
$190.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
647629697 |
|
| 08/01/2019 |
Research |
Cash or cash equivalent |
|
$4820.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629695 |
|
| 08/01/2019 |
Research |
Cash or cash equivalent |
|
$440.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
647629693 |
|
| 05/02/2019 |
Research |
Cash or cash equivalent |
|
$6790.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629691 |
|
| 05/30/2019 |
Research |
Cash or cash equivalent |
|
$12090.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629689 |
|
| 04/04/2019 |
Research |
Cash or cash equivalent |
|
$8650.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629687 |
|
| 02/28/2019 |
Research |
Cash or cash equivalent |
|
$18980.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629685 |
|
| 01/24/2019 |
Research |
Cash or cash equivalent |
|
$4350.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629683 |
|
| 01/17/2019 |
Research |
Cash or cash equivalent |
|
$5420.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
647629681 |
|
| 09/18/2018 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$207.41 |
Details |
| Payment from |
GE HEALTHCARE |
| Payment Record ID |
618339115 |
|
| 09/18/2018 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$59.38 |
Details |
| Payment from |
GE Healthcare |
| Payment Record ID |
615898755 |
|
| 09/18/2018 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$207.41 |
Details |
| Payment from |
GE Healthcare |
| Payment Record ID |
615898751 |
|
| 11/01/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$50.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610858461 |
|
| 01/25/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$150.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609760885 |
|
| 08/30/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2300.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609698329 |
|
| 07/23/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2750.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609698111 |
|
| 06/28/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$350.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609666995 |
|
| 03/08/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$85.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609612873 |
|
| 03/08/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$450.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609612545 |
|
| 03/08/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$100.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609612540 |
|
| 01/25/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$200.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
609612385 |
|
| 05/22/2018 |
General (Non-Research) |
Cash or cash equivalent |
Honoraria |
$1000.00 |
Details |
| Payment from |
BRACCO DIAGNOSTICS INC. |
| Payment Record ID |
605254513 |
|
| 12/20/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$55.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
604788811 |
|
| 11/01/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$810.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
604785613 |
|
| 06/28/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$55.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
604531787 |
|
| 05/24/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1600.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
604420145 |
|
| 05/24/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1600.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
604420143 |
|
| 08/30/2018 |
Research |
Cash or cash equivalent |
Drug |
$990.00 |
Details |
| Payment from |
NOVARTIS PHARMACEUTICALS CORPORATION |
| Paymment Research Study |
A PHASE III OPEN LABEL RANDOMIZED MULTICENTER TRIAL OF OFATUMUMAB MAINTENANCE TREATMENT VERSUS NO FURTHER TREATMENT IN SUBJECTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA CLL WHO HAVE RESPONDED TO INDUCTION THERAPY |
| Payment Record ID |
584630615 |
|
| 03/22/2018 |
Research |
Cash or cash equivalent |
Drug |
$840.00 |
Details |
| Payment from |
Pharmacyclics LLC, An AbbVie Company |
| Paymment Research Study |
PCYC-1112-CA |
| Payment Record ID |
583164027 |
|
| 03/08/2018 |
Research |
Cash or cash equivalent |
Drug |
$1635.00 |
Details |
| Payment from |
Pharmacyclics LLC, An AbbVie Company |
| Paymment Research Study |
PCYC-1112-CA |
| Payment Record ID |
583163897 |
|
| 01/25/2018 |
Research |
Cash or cash equivalent |
Drug |
$7200.00 |
Details |
| Payment from |
Pharmacyclics LLC, An AbbVie Company |
| Paymment Research Study |
PCYC-1112-CA |
| Payment Record ID |
583163883 |
|
| 01/04/2018 |
Research |
Cash or cash equivalent |
Drug |
$17900.00 |
Details |
| Payment from |
Pharmacyclics LLC, An AbbVie Company |
| Paymment Research Study |
PCYC-1112-CA |
| Payment Record ID |
583153339 |
|
| 11/29/2018 |
Research |
Cash or cash equivalent |
|
$2470.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566854229 |
|
| 11/01/2018 |
Research |
Cash or cash equivalent |
Drug |
$3555.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-175 |
| Clinical Trials Gov ID |
NCT03086239 |
| Payment Record ID |
566854227 |
|
| 11/29/2018 |
Research |
Cash or cash equivalent |
Drug |
$485.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-175 |
| Clinical Trials Gov ID |
NCT03086239 |
| Payment Record ID |
566854225 |
|
| 11/01/2018 |
Research |
Cash or cash equivalent |
|
$1330.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566854223 |
|
| 09/27/2018 |
Research |
Cash or cash equivalent |
|
$690.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566845341 |
|
| 08/30/2018 |
Research |
Cash or cash equivalent |
|
$1520.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566844771 |
|
| 07/23/2018 |
Research |
Cash or cash equivalent |
|
$3110.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566844107 |
|
| 06/28/2018 |
Research |
Cash or cash equivalent |
|
$3200.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566840581 |
|
| 04/19/2018 |
Research |
Cash or cash equivalent |
|
$3440.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566828097 |
|
| 03/22/2018 |
Research |
Cash or cash equivalent |
|
$1600.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566827823 |
|
| 03/08/2018 |
Research |
Cash or cash equivalent |
|
$3110.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566827821 |
|
| 01/25/2018 |
Research |
Cash or cash equivalent |
|
$1300.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566827377 |
|
| 01/04/2018 |
Research |
Cash or cash equivalent |
|
$3370.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566827375 |
|
| 05/24/2018 |
Research |
Cash or cash equivalent |
|
$870.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
566827335 |
|
| 03/28/2017 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$94.72 |
Details |
| Payment from |
BRACCO DIAGNOSTICS INC. |
| Payment Record ID |
509184209 |
|
| 03/30/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$200.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506737909 |
|
| 01/03/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$50.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506737907 |
|
| 02/02/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$50.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506737905 |
|
| 02/23/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2900.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506737903 |
|
| 08/03/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$450.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506579521 |
|
| 06/01/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2150.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506579519 |
|
| 09/07/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$150.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506579513 |
|
| 07/13/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1400.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506579511 |
|
| 06/01/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$450.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506574871 |
|
| 09/07/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$200.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506574869 |
|
| 11/22/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2300.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506573195 |
|
| 06/01/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2450.00 |
Details |
| Payment from |
MEDIVATION INC. |
| Payment Record ID |
506455817 |
|
| 09/28/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$750.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506449341 |
|
| 11/02/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$50.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506447121 |
|
| 10/26/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$50.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506446481 |
|
| 11/02/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$85.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
502649577 |
|
| 06/01/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$170.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
502521909 |
|
| 02/02/2017 |
Research |
Cash or cash equivalent |
Drug |
$5240.00 |
Details |
| Payment from |
NOVARTIS PHARMACEUTICALS CORPORATION |
| Paymment Research Study |
A PHASE III OPEN LABEL RANDOMIZED MULTICENTER TRIAL OF OFATUMUMAB MAINTENANCE TREATMENT VERSUS NO FURTHER TREATMENT IN SUBJECTS WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA CLL WHO HAVE RESPONDED TO INDUCTION THERAPY |
| Payment Record ID |
489833342 |
|
| 01/03/2017 |
Research |
Cash or cash equivalent |
|
$660.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
462207659 |
|
| 11/22/2017 |
Research |
Cash or cash equivalent |
|
$100.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
462166983 |
|
| 09/28/2017 |
Research |
Cash or cash equivalent |
|
$1350.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462153077 |
|
| 09/07/2017 |
Research |
Cash or cash equivalent |
|
$8290.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462153071 |
|
| 08/03/2017 |
Research |
Cash or cash equivalent |
|
$1480.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462130437 |
|
| 07/13/2017 |
Research |
Cash or cash equivalent |
|
$3880.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462103517 |
|
| 05/11/2017 |
Research |
Cash or cash equivalent |
|
$3710.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462100805 |
|
| 06/08/2017 |
Research |
Cash or cash equivalent |
|
$12450.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462100317 |
|
| 06/01/2017 |
Research |
Cash or cash equivalent |
|
$5130.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462100313 |
|
| 06/01/2017 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
462100187 |
|
| 02/02/2017 |
Research |
Cash or cash equivalent |
Drug |
$160.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
462099687 |
|
| 02/02/2017 |
Research |
Cash or cash equivalent |
|
$2420.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462099683 |
|
| 01/09/2017 |
Research |
Cash or cash equivalent |
Drug |
$1045.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
462098886 |
|
| 01/05/2017 |
Research |
Cash or cash equivalent |
|
$3530.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462098883 |
|
| 03/30/2017 |
Research |
Cash or cash equivalent |
|
$5920.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
462098593 |
|
| 03/30/2017 |
Research |
Cash or cash equivalent |
Drug |
$1095.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-982 |
| Clinical Trials Gov ID |
NCT01889186 |
| Payment Record ID |
462098589 |
|
| 03/30/2017 |
Research |
Cash or cash equivalent |
|
$150.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
462098579 |
|
| 04/15/2016 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$43.49 |
Details |
| Payment from |
Philips Electronics North America Corporation |
| Payment Record ID |
416357003 |
|
| 05/19/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$6250.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
405729376 |
|
| 04/14/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1575.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
405713366 |
|
| 01/14/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$6225.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
405693784 |
|
| 01/07/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$4525.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
405693722 |
|
| 02/11/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3225.00 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
405693720 |
|
| 06/24/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1275.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
405124846 |
|
| 04/18/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$510.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
403513810 |
|
| 06/24/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$425.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
403402796 |
|
| 05/26/2016 |
Research |
Cash or cash equivalent |
Drug |
$610.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
396294400 |
|
| 02/25/2016 |
Research |
Cash or cash equivalent |
|
$320.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
396293174 |
|
| 11/21/2016 |
Research |
Cash or cash equivalent |
|
$2690.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
396193273 |
|
| 11/03/2016 |
Research |
Cash or cash equivalent |
|
$1770.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
396193223 |
|
| 11/21/2016 |
Research |
Cash or cash equivalent |
|
$360.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
396193156 |
|
| 11/03/2016 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
396193114 |
|
| 10/06/2016 |
Research |
Cash or cash equivalent |
|
$1580.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
396011736 |
|
| 09/15/2016 |
Research |
Cash or cash equivalent |
|
$320.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
395893104 |
|
| 06/24/2016 |
Research |
Cash or cash equivalent |
|
$1280.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
395648916 |
|
| 04/18/2016 |
Research |
Cash or cash equivalent |
Drug |
$1320.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
395410808 |
|
| 04/14/2016 |
Research |
Cash or cash equivalent |
Drug |
$2425.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
395410720 |
|
| 04/21/2016 |
Research |
Cash or cash equivalent |
|
$100.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
395410644 |
|
| 04/21/2016 |
Research |
Cash or cash equivalent |
|
$450.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
395405732 |
|
| 05/19/2016 |
Research |
Cash or cash equivalent |
Drug |
$610.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
395385846 |
|
| 03/28/2016 |
Research |
Cash or cash equivalent |
Drug |
$400.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-982 |
| Clinical Trials Gov ID |
NCT01889186 |
| Payment Record ID |
395104436 |
|
| 02/25/2016 |
Research |
Cash or cash equivalent |
Drug |
$5165.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
394992800 |
|
| 02/11/2016 |
Research |
Cash or cash equivalent |
Drug |
$400.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M13-365 |
| Clinical Trials Gov ID |
NCT01682616 |
| Payment Record ID |
394992624 |
|
| 02/25/2016 |
Research |
Cash or cash equivalent |
|
$550.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
394992594 |
|
| 01/14/2016 |
Research |
Cash or cash equivalent |
|
$50.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-914 |
| Clinical Trials Gov ID |
NCT02163694 |
| Payment Record ID |
394989069 |
|
| 01/21/2016 |
Research |
Cash or cash equivalent |
|
$1220.00 |
Details |
| Payment from |
AbbVie, Inc. |
| Paymment Research Study |
M12-895 |
| Clinical Trials Gov ID |
NCT01506609 |
| Payment Record ID |
394988946 |
|
